AstraZeneca PLC (AZN)
70.82
+0.70
(+0.99%)
USD |
NASDAQ |
Apr 23, 16:00
70.77
-0.04
(-0.06%)
After-Hours: 20:00
AstraZeneca Price: 70.82 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2024 | 69.67 | 70.49 | 69.38 | 70.12 | 4.433M |
| Apr 19, 2024 | 68.14 | 68.71 | 68.13 | 68.55 | 4.736M |
| Apr 18, 2024 | 68.25 | 68.78 | 68.16 | 68.36 | 4.006M |
| Apr 17, 2024 | 68.72 | 68.80 | 68.20 | 68.53 | 3.710M |
| Apr 16, 2024 | 68.29 | 68.60 | 68.02 | 68.26 | 5.362M |
| Apr 15, 2024 | 69.07 | 69.56 | 68.54 | 68.73 | 9.214M |
| Apr 12, 2024 | 69.66 | 69.82 | 68.60 | 68.93 | 9.121M |
| Apr 11, 2024 | 69.88 | 70.07 | 68.87 | 69.45 | 5.986M |
| Apr 10, 2024 | 67.59 | 68.16 | 67.42 | 68.11 | 7.716M |
| Apr 09, 2024 | 68.20 | 68.46 | 67.96 | 68.41 | 4.393M |
| Apr 08, 2024 | 67.57 | 67.77 | 67.22 | 67.70 | 3.825M |
| Apr 05, 2024 | 66.98 | 67.72 | 66.89 | 67.45 | 4.811M |
| Apr 04, 2024 | 68.99 | 68.99 | 67.29 | 67.34 | 7.454M |
| Apr 03, 2024 | 66.40 | 67.35 | 66.38 | 66.81 | 3.796M |
| Apr 02, 2024 | 67.15 | 67.38 | 66.76 | 67.00 | 4.397M |
| Apr 01, 2024 | 68.20 | 68.22 | 67.04 | 67.25 | 3.114M |
| Mar 28, 2024 | 68.18 | 68.35 | 67.68 | 67.75 | 3.617M |
| Mar 27, 2024 | 67.08 | 68.38 | 67.06 | 68.26 | 8.444M |
| Mar 26, 2024 | 66.25 | 66.46 | 65.76 | 66.33 | 3.133M |
| Mar 25, 2024 | 66.21 | 66.43 | 65.80 | 65.86 | 4.425M |
| Mar 22, 2024 | 66.49 | 66.84 | 66.20 | 66.26 | 4.099M |
| Mar 21, 2024 | 66.61 | 66.79 | 66.18 | 66.19 | 5.352M |
| Mar 20, 2024 | 65.57 | 65.88 | 65.20 | 65.73 | 3.553M |
| Mar 19, 2024 | 65.60 | 65.90 | 65.25 | 65.86 | 3.403M |
| Mar 18, 2024 | 66.01 | 66.37 | 65.80 | 65.85 | 3.887M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.28
Minimum
May 13 2019
75.81
Maximum
Apr 24 2023
57.88
Average
57.89
Median
Jul 30 2020
Price Benchmarks
| GSK PLC | 41.22 |
| Amgen Inc | 273.60 |
| Sanofi SA | 47.71 |
| Viking Therapeutics Inc | 64.95 |
| Fusion Pharmaceuticals Inc | 21.40 |
Price Related Metrics
| PE Ratio | 36.98 |
| PS Ratio | 4.829 |
| PEG Ratio | 0.4537 |
| Price to Book Value | 5.609 |
| Price to Free Cash Flow | 33.69 |
| Earnings Yield | 2.70% |
| Market Cap | 219.55B |
| PEGY Ratio | 0.4424 |
| Operating PE Ratio | 25.36 |
| Normalized PE Ratio | 34.68 |